TPG-Axon raises position in GNC Holdings


Nov. 20 2020, Updated 2:28 p.m. ET

TPG-Axon and GNC Holdings

TPG-Axon increased its position in GNC Holdings (GNC) during 3Q14. The stock accounts for 18.83% of the total portfolio, up from 9.65% of the fund’s 2Q14 portfolio.

Article continues below advertisement

About GNC Holdings

GNC Holdings is a leading global specialty retailer of health and wellness products, including:

  • vitamins
  • minerals
  • herbal supplement products
  • sports nutrition products
  • diet products

The company operates a diversified, multichannel business model that earns revenue from product sales through:

  • company-owned retail stores
  • domestic and international franchise activities
  • third-party contract manufacturing
  • e-commerce
  • corporate partnerships

As of September 30, 2014, GNC had more than 8,800 locations. Over 6,500 of these locations are retail locations in the US.

3Q14 revenue missed estimates

For 3Q14, GNC reported consolidated revenues of $656.3 million. This was a decrease of 2.7%, compared to $674.5 million for 3Q13. Revenue fell in each of the company’s segments:

  • Retail revenue fell by 1.4% due to negative same-store sales
  • Franchise revenue fell by 3.1% due to fewer wholesale product sales from international franchise operations
  • Manufacturing and wholesale revenue fell by 11.4% due to lower third-party contract manufacturing revenue

In 3Q14, same-store sales—as measured on a product-only basis—decreased 6.9% in domestic company-owned stores, including GNC.com. In contrast, these sales increased by 8.2% in 3Q13. Same-store and GNC.com sales decreased 5.8% in domestic company-owned stores in 3Q14, including the sales of the Gold Card, which GNC offered to customers free of charge during the member pricing launch in May and June 2013. In domestic franchise locations, same-store sales decreased 4.5% in 3Q14.

For 3Q14, GNC reported generally accepted accounting principles (GAAP) net income of $64.3 million. Adjusted diluted earnings per share were $0.75, compared to $0.76 in 3Q13.

Article continues below advertisement


On November 24, 2014, GNC launched its GNC PUREDGE line of health, wellness, and performance supplements, which are based on whole foods. These products don’t have any GMOs (genetically modified organisms), added ingredients, or gluten-added ingredients.

TPG-Axon’s notable positions traded in 3Q14

TPG-Axon started new positions in Alibaba Group Holding (BABA), Zynga (ZNGA), and Allison Transmission Holding (ALSN). It raised positions in GNC Holdings (GNC) and Monsanto Co (MON). It exited positions in Time Warner (TWX), and Equinix (EQIX). It reduced its positions in SandRidge Energy (SD).

In the next part of this series, we will explore TPG-Axon’s position in Monsanto.


More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.